September 11, 2024
This is the third in a three-part series from Medscape on the impact of AI on drug discovery and development. Part 1 is about AI’s role […]
September 11, 2024
The glucagon-like peptide 1 (GLP-1) receptor agonist liraglutide is the first in its class to show benefits in young children with obesity, according to results from […]
September 11, 2024
The glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide is the first in its class to show benefits in young children with obesity, according to results from the […]
September 11, 2024
TOPLINE: MRI-derived abdominal adipose tissue is linked to chronic musculoskeletal pain in multiple sites. The association is stronger in women, suggesting sex differences in fat distribution […]
September 11, 2024
The antibody-drug conjugate ifinatamab deruxtecan (I-DXd) is effective in extensive-stage small cell lung cancer (ES-SCLC), with a higher dose of the drug almost doubling the response […]
September 11, 2024
This is the second in a three-part series from Medscape Medical News on the impact of artificial intelligence (AI) on drug discovery and development. Part 1 […]
September 11, 2024
SAN DIEGO — Treatment with the estimated glomerular filtration rate (EGFR) tyrosine kinase inhibitor (TKI) aumolertinib after chemoradiation was associated significant improvement in progression-free survival compared […]
September 11, 2024
TOPLINE: Nailfold capillaroscopy identifies distinct changes in capillary density, length, and morphology in patients with conditions such as nail psoriasis, onychomycosis, and retronychia. METHODOLOGY: The single-center, […]
September 11, 2024
A recent surge in cases of eastern equine encephalitis (EEE) in the northeastern United States, likely brought on by warm weather–induced faster disease spread, has prompted […]